- « Previous
- Clinical Pharmacology
- Next »
Kineret
Clinical Pharmacology
Kineret
ACR70
Month 3
0%
3%a
0%
0%
0%
Month 6
2%
6%a
1%
1%
1%
a p< 0.05, Kineret® versus placebo
b p< 0.01, Kineret® versus placebo
c p< 0.001, Kineret® versus placebo
Table 2: Median ACR Component Scores in Study 1 |
|||||
Placebo/MTX |
Kineret®/MTX |
||||
Parameter (median) |
Month 6 |
Baseline |
Month 6 |
||
Patient Reported Outcomes |
|||||
Disability indexa |
1.38 |
1.13 |
1.38 |
1.00 |
|
Patient global assessmentb |
51.0 |
41.0 |
51.0 |
29.0 |
|
Painb |
56.0 |
44.0 |
63.0 |
34.0 |
|
Objective Measures |
|||||
ESR (mm/hr) |
35.0 |
32.0 |
36.0 |
19.0 |
|
CRP (mg/dL) |
2.2 |
1.6 |
2.2 |
0.5 |
|
|
Brand Name: Kineret
Generic Name: Anakinra
ArthritisGet the latest treatment options
WebMD Resources
| |||||
